SUNDARARAJU AROKIASWAMY .

      DIN: 00003260

      For latest information about the director, visit MCA.

      SUNDARARAJU AROKIASWAMY . is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 00003260. SUNDARARAJU AROKIASWAMY . is/has been associated with 23 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      SUMATHI INFRA PROJECT LLP Designated Partner 29-Mar-2016
      THYROCARE PUBLICATIONS LLP Designated Partner 30-Mar-2016
      MAHIMA ADVERTISING LLP Designated Partner 30-Mar-2016
      ELAYA AGRO LLP Designated Partner 11-Jan-2023
      MAHIMA ADVERTISING PRIVATE LIMITED Director 26-Aug-2002
      IHEART PROPERTIES PRIVATE LIMITED Director 10-May-2002
      DEE ANU TRADING CO PVT LTD Director 01-Apr-2008
      PAVILION COMMERCIAL PVT LTD Director 01-Apr-2001
      THYROCARE PUBLICATIONS PRIVATE LIMITED Director 10-May-2002
      SUMATHI INFRA PROJECT PRIVATE LIMITED Director 22-Feb-2007
      THYROCARE INTERNATIONAL LIMITED Director 14-May-2012
      IBRAIN ENTERPRISES PRIVATE LIMITED Director 16-Aug-2001
      SUMATHI HEALTHCARE PRIVATE LIMITED Director 22-Feb-2007
      IHEART RESORTS PRIVATE LIMITED Director 01-Jul-2006
      TOTAL T3T4TSH DIAGNOSTICS PRIVATE LIMITED Director 19-Jan-2004
      IBRAIN RESORTS LIMITED Director 05-Dec-2005
      APPU HOTELS LIMITED Nominee Director 26-Feb-2024

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      APLAYA CREATIONS LIMITED Director 06-Mar-2002 04-Feb-2011
      THYROCARE TECHNOLOGIES LIMITED CFO(KMP) 14-Mar-2015 02-Sep-2021
      THYROCARE TECHNOLOGIES LIMITED Director 28-Jan-2000 01-Apr-2009
      THYROCARE TECHNOLOGIES LIMITED Whole-time director 01-Apr-2009 02-Sep-2021
      NUECLEAR HEALTHCARE LIMITED CFO(KMP) 22-Jun-2015 02-Sep-2021
      NUECLEAR HEALTHCARE LIMITED Director 31-Jan-2011 02-Sep-2021

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales